People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biostage, Inc. | — | Biotechnology | Series A | $36.5M | $1.8M | 2016 |
| Elliptic Enterprises Ltd | — | Other Technology | Series B | $30.7M | $673.9M | 2016 |
| Cytovia Holdings, Inc. | — | Biotechnology | Series A | $11.5M | $12.8M | 2022 |
Thomas Robinson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Robinson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Smith | 1 | 20 |
| David Green | 1 | 8 |
| Wei Li | 1 | 7 |
| Walter Kortschak | 1 | 6 |
| John Kennedy | 1 | 6 |
| Christopher Steed | 1 | 5 |
| Michael Friedman | 1 | 4 |
| Jing Chen | 1 | 3 |
| Gregory Fiore | 1 | 3 |
| MICHAEL NOONAN | 1 | 3 |
| Ting Li | 1 | 3 |
| Wei Zhang | 1 | 3 |
| Ronald Packard | 1 | 2 |
| Blaine McKee | 1 | 2 |
| Thomas McNaughton | 1 | 2 |
| Junli He | 1 | 1 |
| William Fodor | 1 | 1 |
| James McGorry | 1 | 1 |
| Joseph Damasio | 1 | 1 |
| Mao Zhang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.